Being Right Isn’t Enough in the Stock Market

In the stock market, good analysis does not guarantee a good investment. Even when they correctly anticipate how a company will evolve, investors can lose money. In financial markets, being right is not enough; you have to be right at the right time.

The stock market is unforgiving. And paradoxically, that is part of its appeal. Investors can spend hours poring over annual reports, dissecting companies’ financial statements or scrutinizing charts to identify trends and determine the best entry and exit points. Despite all these efforts, even the most experienced investors get things wrong. If the stock market punishes those who are wrong, it is sometimes even harsher on those who are right.

Imagine an investor capable of predicting a company’s bankruptcy with certainty. Convinced by his analysis, he decides to short the stock to profit from its decline. Yet, against all expectations, the share price continues to rise. Losses mount until a margin call forces him to liquidate his position. A few weeks later, the company goes bankrupt. The investor was right, but he lost money.

This situation illustrates one of finance’s most famous sayings, generally attributed to John Maynard Keynes: “The market can stay irrational longer than you can stay solvent.”

In the stock market, being right too early is sometimes the same as being wrong.

If seasoned analysts, despite being capable of producing rigorous analysis, fail to anticipate market movements, it is not necessarily because their reasoning is wrong. It is often because their scenario does not play out when they expected it to.

The reason lies in part in a particular feature of financial markets: share prices reflect not only companies’ prospects, but also investors’ expectations about those prospects. And above all, the way those expectations evolve.

When the stock market becomes a beauty contest

A little economics never hurts, especially when John Maynard Keynes enters the financial markets with metaphors. In Chapter 12 of his General Theory of Employment, Interest and Money, published in 1936, the economist used the image of a beauty contest. The comparison became famous, illustrating quite accurately some of the forces driving investor psychology.

His insight is simple. In financial markets, a stock’s price depends not only on its fundamental value. It also reflects, and sometimes primarily reflects, investors’ perception of that value.

A company’s growth prospects, expected earnings and the outlook for its industry naturally influence its valuation. But these factors are not enough. What also matters is how other investors interpret them.

To illustrate this mechanism, Keynes drew on beauty contests organized by newspapers of his time. Readers had to select the six most beautiful faces from a hundred photographs. The winner was not the person who chose the most attractive candidates according to his or her own preferences, but the one whose selection came closest to the choice of all participants.

In other words, to win, participants did not have to choose the most beautiful candidates, but to guess which ones others would consider the most beautiful, and therefore come as close as possible to the consensus. A rational participant therefore does not seek to express personal preferences. He or she tries to anticipate those of others. And because every participant may follow the same reasoning, the game consists of guessing what others think others will choose.

For Keynes, the stock market partly operates according to this logic. In the short term, a stock’s price depends less on its intrinsic value than on investors’ collective expectations. This phenomenon is particularly visible in the most speculative stocks, whose prices can fluctuate considerably without any equivalent change in their fundamentals.

Back to the future: expectations dictate prices

Therefore, being right about a company’s prospects does not guarantee making money in the stock market. A company may show excellent financial health, report sharply higher earnings and still see its stock fall.

Portuguese group Galp Energia, one of Europe’s leading oil and gas companies, offers an illustration today. Its stock is down nearly 10% despite solid profitability and the publication of adjusted net income up 68% to €682m.

Investors appear more concerned about the failure of negotiations with Spanish group Moeve, which sought to bring together their refining, chemicals and fuel distribution operations.

They had apparently priced in some of the profits expected from the deal. Its abandonment is prompting them to revise their outlook and potentially the stock’s valuation. Strong financial results are not enough to offset this disappointment.

For a buyer convinced of Galp’s long-term potential, the situation may seem absurd. His fundamental analysis may remain perfectly valid. Yet if he bought the stock just before the announcement, he could suffer an unrealized loss of nearly 10% on his very first session as a holder. He was not necessarily wrong about the company. He may simply have been wrong about when to invest.

A matter of timing

This apparent contradiction can be explained by the behavior of economic agents. In financial markets, everyone seeks to anticipate the moves of others in order to buy before a rise or sell before a decline. The goal is not only to identify promising companies, but to take a position before their potential is fully recognized by the market.

It is not enough to predict what will happen, you must also anticipate when the market will price in the information. The entry point then becomes an essential performance variable. Two investors can share exactly the same analysis of a company and achieve radically different results depending on when they buy its stock.

This does not mean investors should abandon fundamental analysis in favor of speculation. On the contrary, understanding a company’s economic and financial prospects remains essential. But this analysis must be accompanied by consideration of the expectations already priced into the stock.

In the stock market, a good company does not necessarily make a good stock. It all depends on the price paid, the expectations already priced in and the company’s ability to exceed them. Investors must therefore ask not only what will happen, but also what others think will happen. This question of timing is particularly important for traders seeking to realize capital gains quickly and who sometimes use derivatives or leveraged products.

Source link

Visited 1 times, 1 visit(s) today

Related Article

Stock Market: Will S&P 500 Open Up or Down Today?

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. View more earnings on SPY U.S. stock futures are trading mixed to slightly higher early Tuesday as investors juggle a flood of corporate earnings, the start of a critical Federal Reserve policy meeting, and blockbuster IPO news from

RKLB Stock Edges Up Overnight: Neutron’s Second Stage Heads To Launch Site — Analyst Eyes Q2 2027 Debut And Shares Doubling

Rocket Lab shipped Neutron hardware toward its Virginia launch site. The second stage and thrust module are headed to Wallops for launch-pad systems testing. Electron recently completed its 98th mission, deploying three HawkEye 360 satellites on Rocket Lab’s 19th launch of 2026. Rocket Lab (RKLB) shares rose 0.3% overnight heading into Tuesday after the company

Should You Buy Markel Stock (MKL) on the Dip?

Shares of Markel (NYSE: MKL) were down 13% year-to-date as of Oct. 23. That could make an investor wonder: Is this a good time to buy into Markel? Here’s my take. For starters, know that Markel has long been referred to as a “mini-Berkshire” because of similarities to Warren Buffett’s Berkshire Hathaway. But there are

XP (XP) Stock Still Appears Undervalued After the 48% Slide

XP Inc. has just seen a sharp share price reset, and the question now is whether the current market value lines up with the returns it earns on its capital. After a politically charged selloff in Brazil, investors are weighing if the business performance behind XP stock justifies where the price has landed. The share

Is COVER Corporation (TSE:5253) Potentially Undervalued?

While COVER Corporation (TSE:5253) might not have the largest market cap around , it saw a decent share price growth of 12% on the TSE over the last few months. The recent rally in share prices has nudged the company in the right direction, though it still falls short of its yearly peak. With many

Wall Street’s Blockbuster Stock Split Was Just Announced, and It’s Anything but Conventional

Although artificial intelligence (AI) has been the hottest thing since sliced bread, it’s not the only trend responsible for lifting the stock market to new heights. Investors gravitating toward Wall Street’s premier stock-split stocks have also played a key role in the market’s outperformance. Several high-profile stock splits have been announced this year, including cybersecurity

The markets are starting to act seriously weird. Blame AI

On the surface, the markets seem stable. Stocks are near record highs, and bonds are right about where they’ve been for the past couple of months. But check under the hood, and you’ll see signs that investors are growing increasingly nervous — mostly because of AI. This time, the anxiety isn’t because AI is going

This warning sign suggests more tech stock poundings could be in the cards

The tech trade could have some sharper down days ahead if the red flags in the bond market are to be believed. Hyperscaler credit default swaps continue to widen, BTIG strategist Jonathan Krinsky pointed out. Investment-grade tech credit default swaps are now the widest they’ve been since 2022. Yet, the S&P Tech Sector is just

The 10 biggest stocks are faltering, and it’s dragging the S&P 500 down

Apple (AAPL) and Nvidia (NVDA) may be renewing their battle for the world’s most valuable company, but a challenging few months for the S&P 500’s (^GSPC) 10 largest companies are holding back the broader index. The 10 biggest stocks in the S&P 500 have started to falter again relative to the rest of the market,

5 Stocks to Buy Trading at Big Discounts

Key Takeaways What’s behind the artificial intelligence selloff and rally in Treasury bonds. Expectations for the October Federal Reserve meeting. What to watch in upcoming earnings from Alphabet GOOG/GOOGL, Microsoft MSFT, and Amazon.com AMZN. Is Hasbro HAS still a buy after earnings? What slowing growth at Netflix NFLX means for the stock. How to incorporate

Lycia leaps onto Nasdaq with upsized $318M IPO as Windward breezes toward listing

Lycia Therapeutics went public with an upsized $317.5 million IPO on Friday, while immunology-focused Windward Bio has also seen which way the public markets are blowing. South San Francisco-based Lycia offered 17.6 million shares as part of its Friday listing—above the 14.7 million shares that the company had previously expected. At $18 apiece, the shares

Prediction: This Magnificent Seven Stock Could Be a $1 Trillion Opportunity

Quick Read Alphabet (GOOG) earns a BUY with a $423.95 price target as Google Cloud grew 82% and its backlog hit $514 billion. Alphabet trades at just 13x trailing earnings versus Microsoft (MSFT) at 29x and Meta (META) at 24x, while growing revenue faster than both. Just released. Our analysts combed the entire stock market

Capital markets expected to mobilise over $386 billion for 2026–2030 growth

A trader talks to a customer in the trading room of a securities firm in Hà Nội. — VNA/VNS Photo HÀ NỘI — The capital markets are expected to provide around VNĐ10 quadrillion (US$386.5 billion) towards meeting the country’s investment needs during 2026–2030, as the Government targets annual economic growth of at least 10 per

How Sam Altman, ChatGPT and AI-Driven Cyberattacks are influencing the Stock Markets

Artificial intelligence is transforming cybersecurity, but it is also creating new risks for businesses, governments and financial markets. Under Sam Altman’s leadership, OpenAI has helped bring advanced AI tools into mainstream use through ChatGPT. However, as AI systems become increasingly capable of identifying software vulnerabilities and executing complex tasks, concerns about cyberattacks are beginning to

Aktsiaselts Infortar own share acquisition transactions

Aktsiaselts Infortar acquired its own shares on the Nasdaq Tallinn Stock Exchange during the period of 19 October – 23 October 2026 as follows: Date Aggregated volume (pcs) Weighted average price per day (EUR) 19.10.2026 195 65,0154 20.10.2026 242 65,3025 21.10.2026 240 68,9167 22.10.2026 244 68,6459 23.10.2026 246 67,8407 Aktsiaselts Infortar is acquiring its own shares

Billionaire Ken Griffin Is Buying This Dividend King That Wall Street Still Rates a Buy

Billionaire Ken Griffin’s Citadel Advisors has been increasing its stake in drugmaker AbbVie (NYSE: ABBV) in recent months. In the second quarter, Citadel purchased 2.7 million shares of AbbVie at an average price of $234.57, for a total investment of about $633 million. That takes Citadel’s stake in AbbVie to 3.2 million shares, worth $909

0
Would love your thoughts, please comment.x
()
x